Page 1 of Clinical Trials for Procedure enzyme inhibitor therapy, 16967 Total Matches
- 1Active, not recruitingLast Updated: April 20, 2011Condition(s): Solid Tumor
- 2TerminatedLast Updated: January 22, 2008Condition(s): Kidney Cancer
- 3CompletedLast Updated: March 3, 2008Condition(s): Atherosclerosis; Coronary Disease; Vasculitis
- 4WithdrawnLast Updated: June 14, 2006Condition(s): Stage 0 Cervical Cancer; High-Grade Squamous Intraepithelial Lesion
- 5RecruitingLast Updated: February 21, 2008Condition(s): Acute Renal Failure
- 6WithdrawnLast Updated: December 4, 2006Condition(s): Non-Small Cell Lung Cancer
- 7WithdrawnLast Updated: October 24, 2006Condition(s): Gastrointestinal Carcinoid Tumor; Islet Cell Carcinoma
- 8TerminatedLast Updated: January 24, 2008Condition(s): Esophageal Cancer
- 9TerminatedLast Updated: January 24, 2008Condition(s): Lymphoma
- 10Active, not recruitingLast Updated: April 25, 2012Condition(s): Adenocarcinoma of the Esophagus; Adenocarcinoma of the Gastroesophageal Junction; Adenocarcinoma of the Stomach; Squamous Cell Carcinoma of the Esophagus; Stage II Esophageal Cancer; Stage II Gastric Cancer; Stage III Esophageal Cancer; Stage III Gastric Cancer
- 11TerminatedLast Updated: February 20, 2008Condition(s): Leukemia
- 12WithdrawnLast Updated: January 11, 2007Condition(s): Stage IV Renal Cell Cancer; Recurrent Renal Cell Cancer
- 13RecruitingLast Updated: March 13, 2012Condition(s): Male Breast Cancer; Recurrent Breast Cancer; Stage IV Breast Cancer
- 14RecruitingLast Updated: May 1, 2012Condition(s): Anaplastic Large Cell Lymphoma; Angioimmunoblastic T-cell Lymphoma; Hepatosplenic T-cell Lymphoma; Peripheral T-cell Lymphoma
- 15CompletedLast Updated: June 23, 2005Condition(s): Kidney Disease; Diabetic Nephropathy; Glomerulonephritis; Proteinuria
- 16RecruitingLast Updated: May 15, 2012Condition(s): Bone Metastases; Castrate-resistant Prostate Cancer; Recurrent Prostate Cancer; Stage IV Prostate Cancer
- 17RecruitingLast Updated: April 12, 2012Condition(s): Recurrent Adult Diffuse Large Cell Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Mantle Cell Lymphoma
- 18TerminatedLast Updated: May 7, 2012Condition(s): Estrogen Receptor-positive Breast Cancer; HER2-negative Breast Cancer; Male Breast Cancer; Recurrent Breast Cancer; Stage II Breast Cancer; Stage IIIA Breast Cancer; Stage IIIB Breast Cancer
- 19RecruitingLast Updated: April 9, 2012Condition(s): Acinar Cell Adenocarcinoma of the Pancreas; Duct Cell Adenocarcinoma of the Pancreas; Recurrent Pancreatic Cancer; Stage IV Pancreatic Cancer; Unspecified Adult Solid Tumor, Protocol Specific
- 20RecruitingLast Updated: April 16, 2012Condition(s): Unspecified Adult Solid Tumor
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Procedure+enzyme+inhibitor+therapy
